Purpose: In the present study, six flavonoids (5,7-dimethoxyflavanone-4'-O-β-D-glucopyranoside, 5,7-dimethoxyflavanone-4'-O-[2''-O-(5'''-O-trans-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucopyranoside, naringenin-7-O-β-D-glucopyranoside, 5,7,3'-trihydroxy-flavanone-4'-O-β-D-glucopyranoside, rutin, and nicotiflorin) isolated from Galium fissurense, Viscum album ssp. album and Cirsium hypoleucum were screened against extended-spectrum β-lactamase producing multidrug-resistant (trimetoprimesulphametoxazole, sulbactam-ampicillin, clavulonate-amoxicilin, ceftriaxon, cefepime, imipenem, ceftazidime, tobramicin, gentamicin, ofloxacin, ciprofloxacin) 
INTRODUCTION
Multiple drug resistance has significantly increased in recent years. The existence of enzymes of extended-spectrum β-lactamases (ESβLs) producing organism that are resistant to virtually all β-lactam antibiotics have been reported 1 . ESβLs are plasmid-mediated class A enzymes commonly found in the family Enterobacteriaceae, mainly K. pneumoniae 2 . These microorganisms are Gram-negative rods that cause bacterial pneumonia and hospital-acquired infections 3 . The increase in ESβL-producing organisms is sure to create significant therapeutic problems in the future. The available treatment regimens for infections caused by ESβL-producing bacteria are not always effective. Therefore, it is necessary to discover new antimicrobial compounds against ESβL-producing K. pneumoniae strains. Flavonoids occur as aglycones, glycosides and methylated derivatives and are widely distributed in the plant kingdom. They have been reported to possess a variety of biological activities including antiallergic, antidiabetic, antiinflammatory, antiviral, antiproliferative and anticarcinogenic, hepatoprotective, and antioxidant activities. Since these secondary metabolites are synthesized by plants in response to microbial infection, it should not be surprising that they have been found in vitro to be effective antimicrobial substances against a wide array of microorganisms [4] [5] [6] . Also, their antimicrobial activities against some Gram-negative and Gram-positive bacteria have been reported in many papers 2 . Therefore, the flavonoids may be promising new class compounds in antimicrobial therapy. In this study, six flavonoids isolated from three medicinal plants, which are used in Turkish folk medicine, were screened against K. pneumoniae. Galium fissurense Ehrend. & Schönb.-Tem. (Rubiaceae), which is an endemic plant in Turkey, has long been used in folk medicine for a variety of purposes, especially as a diuretic, astringent, choleretic and in the treatment of some stomach, gout and epilepsy 7 . Viscum album L. (Loranthaceae) is reported to have various biological activities such as hypoglycemic, anti-inflammatory, anti-viral, anti-atherogenic, and analgesic activities. On the other hand, we have previously shown that the extracts of V. album ssp. album have inhibitory effects on IL-1α 8 . In folk medicine, the decoction of Cirsium sp. (Asteraceae) seeds and roots is used for healing hemorrhoids and the flowers are a good remedy for peptic ulcer. In addition, the stem is also used for treating ailments such as cough and bronchitis in Anatolia . In a previous work of our group 
2) was also isolated from the nbutanol extract of the same plant using several chromatographic methods . From the n-butanol extract of C. hypoleucum aerial parts (Asteraceae), after multi-stage column chromatographies, two flavonoids, quercetin-3-O-rutinoside (rutin) (5) and kaempferol-3-Orutinoside (nicotiflorin) (6) were previously obtained 9 . The structures of isolated compounds were elucidated by conventional methods of analysis, as well as by different NMR and MS techniques.
Microbiological studies Preparation of the test materials
The flavonoids were dissolved in dimethylsulphoxide to a concentration of 256 µg ml -1 and sterilized by filtration using 0. .
Microorganisms and Inoculum preparation

Confirmatory test for ESβL-producing K. pneumoniae isolates
The double-disc synergy and agar diffusion tests were used as screening tools to detect ESβL-producing strains. In the double-disc synergy test, the antibiotic discs (Oxoid) used were cefotaxime (30 µg) and ceftazidime (30 µg) placed on Mueller-Hinton agar adjacent to a co-amoxiclav disc (20µg amoxicillin plus 10µg clavulanate). The procedures and interpretation of the double-disc synergy test were described previously
14
. The agar diffusion test was performed according to NCCLS guidelines 12 . A ≤5 mm increase in a zone diameter for either ceftazidime/clavulanic acid (30 µg/ 10 µg) or cefotaxime/clavulanic acid (30 µg/ 10 µg) versus its zone when tested alone was taken as being indicative of ESβL-production 15 .
Antimicrobial activity evaluation
The microdilution method was employed for antibacterial tests. Media were placed into each 96 wells of the microplates. Sample solutions at 256 µg ml -1 were added into first rows of microplates and two-fold dilutions of the compounds (128-0.0312 µg ml -1 ) were made by dispensing the solutions into the remaining wells. 10 µl culture suspensions were inoculated into all the wells. The sealed microplates were incubated at 35ºC for 18h. The lowest concentration of the flavonoids that completely inhibit macroscopic growth was determined and the MICs were recorded 16 . fissurense, respectively 7, 11 . When compared with control agents (ampicillin and ofloxacin), all of the tested flavonoids (1-6) showed remarkable activities against isolated strains of all K. pneumoniae at 32 and 64 µg ml [7] [8] [9] were inhibited at a concentration of 64 µg ml -1 by the tested flavonoids, the observed activities being twice the dose of ampicillin and ofloxacin (32 µg ml 
DISCUSSION
Plasmid-mediated ESβLs pose a worldwide resistance problem. These isolates are usually resistant to all aminoglycosides, thirdand fourth-generation cephalosporins and monobactams. Such isolates are involved frequently in outbreaks of infection, particularly in high-risk areas, such as intensive care or neonatal units. Since the discovery of ESβL-producing coliforms in the mid-1980s, over 100 types of different enzymes have been described and have become a worldwide problem. Thus, the members of Enterobacteriaceae producing ESβL are a clinical threat and have been associated with increasing mortality in patients with severe infection. ESβLs are mutant enzymes, which derived from TEM or SHV (class A) enzymes. They confer variable levels of resistance to cefotaxime, ceftazidime and other broad-spectrum cephalosporins and to monobactams such as aztreonam. Thus, the choice of effective and safe drugs to be used against ESβL is shrinking rapidly. Therefore, in recent years, researches are increasingly turning their attention to folk medicine for new leads to develop better drugs against clinical ESβL-producing K. pneumoniae isolates 2, [17] [18] [19] In this study, structure-activity relationships do not appear to play a role here as all six flavonoids exhibited similar MICs (32-64 µg ml -1 ) against all of the K. pneumoniae strains. We observed that active flavonoids 3-6 have an obligatory C-4 keto group and hydroxyl group substitutions at C-5 and have at least one hydroxyl group on ring B. These results are in consonance with the findings of Xu and Lee 19 . On the other hand, although the other active flavonoids 1 and 2 have methoxyl group substitutions at C-5 and C-7, these compounds also exhibited antimicrobial activity against K. pneumoniae at similar MICs values to those of ampicillin and ofloxacin. Alcaraz et al and Xu and Lee demonstrated that substitution with methoxyl groups drastically decreased the antibacterial of flavonoids 20, 21 . Additionally, it is reported that rutin (5) from Linum capitatum Kit. flowers inhibited the growth of P. aeruginosa, but did not show any activity against E. coli different from other Gram-negative bacteria 21 . According to the other report, the same compound tested by the disc-diffusion method showed no activity against K. pneumoniae ATCC 13883 20 . These inconsistencies may be due to variations within each assay. Furthermore, it was not stated whether the test flavonoids were obtained from a commercial or natural source. To the best of our knowledge, this is the first report on the inhibitory activity of 5,7-
, and nicotiflorin (6) against ESβL-producing K. pneumoniae isolates.
CONCLUSION
All the flavonoids (1-6) showed in vitro antimicrobial activity against all the isolated strains of K. pneumoniae, similar to that produced by the control antibacterial (ofloxacin) at the concentration of 32-64 µg ml -l ; on the other hand, another control, ampicillin, had no activity. To the best of our knowledge, this is the first report of the evaluation of the activity of these flavonoids against (ESβL)-producing K. pneumoniae. On the basis of these data presented, these flavonoids may be considered potential therapeutic compounds for infections that may be caused by ESβL-producing bacteria in the future. Therefore, further work is under way to identify their precise antibacterial mechanism. Additionally, the antimicrobial activity of some antibacterials in combination with these flavonoids against extended-spectrum β-Lactamase (ESβL)-producing K. pneumoniae may also need to be evaluated for the treatment of infections caused by ESβL-producing bacteria. 
REFERENCES
